CNX-774 M SE Smiles: CCCNC1C=CC2=NC=C(C3C=CN=CC=3)N2N=1

Smiles: CCCNC1C=CC2=NC=C(C3C=CN=CC=3)N2N=1

Clin Infect Dis

16(22)23)13(18)6-10-20(14

Currently it is in Phase II/III clinical trials for Hodgkin's lymphoma and advanced breast cancer

PubMed PMID: 23972441

CNX-774 M SE Smiles: CCCNC1C=CC2=NC=C(C3C=CN=CC=3)N2N=1CNX 774 is a potent Btk inhibitor (IC50 < 1 nM). Recently Bruton's tyrosine kinase (BTK) , a crucial terminal kinase enzyme in the B cell antigen receptor (BCR) signaling pathway, has emerged as an attractive target for therapeutic intervention in human malignancies and autoimmune disorders. Product information CAS Number: 1202759 32 7 Molecular Weight: 499. 50 Formula: C26H22FN7O3 Chemical Name: 4 {4 [(5 fluoro 4 {[3 (prop 2